Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
7.59M
-
Shares change
-
+874K
-
Total reported value, excl. options
-
$103M
-
Value change
-
+$10.8M
-
Put/Call ratio
-
1.12
-
Number of buys
-
37
-
Number of sells
-
-35
-
Price
-
$13.59
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q3 2020
109 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q3 2020.
Co-Diagnostics, Inc. - Common Stock (CODX) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.59M shares
of 38.5M outstanding shares and own 19.69% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.8M shares), VANGUARD GROUP INC (1.46M shares), Nuveen Asset Management, LLC (648K shares), STATE STREET CORP (460K shares), GEODE CAPITAL MANAGEMENT, LLC (360K shares), NORTHERN TRUST CORP (303K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (282K shares), MORGAN STANLEY (181K shares), WELLS FARGO & COMPANY/MN (162K shares), and IFG Advisory, LLC (143K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.